Symptoms and Signs Clinical Trial
Official title:
Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air for 6.6 Hours With Moderate Exercise in Healthy Young Adults
Purpose: The primary purpose of this study is to measure pulmonary function, symptoms, and pulmonary inflammatory responses in healthy young adults during and immediately after exposure to a low concentration of ozone (0.070 ppm) or clean air for 6.6 hours while undergoing moderate intermittent exercise. This concentration is the current EPA NAAQS standard for ozone.
Potential health effects of ozone have been extensively studied over decades at various levels of exposure concentration and for varying time periods in young healthy adult subjects. Effects of ozone have been well documented particularly for decrements of lung function and an influx of neutrophils and other markers of pulmonary inflammation. The majority of those studies were done at ozone concentrations between 0.12 and 0.40 ppm, considerably higher than the current EPA NAAQS ozone standard of 0.070 ppm, and at exposure durations of two hours, even though the current standard is an 8-hour standard. However, a small number of studies have assessed changes in lung function following exposure to low levels of ozone for several hours. These latter studies have shown that exposure to ozone for 6.6 hours at concentrations between 0.06 and 0.08 ppm causes mild reversible decrements in lung function (1.7-10%) as measured by forced vital capacity (FVC) and forced expired volume at 1 s (FEV1) immediately after exposure in healthy young adults. In addition, in one study an increase in ozone-induced neutrophils was seen in induced sputum following exposure to 0.06 ppm ozone (8) and in bronchoalveolar lavage fluid) following exposure to 0.08 ppm ozone (9). The EPA is considering whether the current ozone NAAQS standard at 0.070 is protective and has asked EPA researchers to conduct a study similar to those done at 0.06 and 0.08 ppm. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04892004 -
Symptom Recognition Improves Self-care in Patients With Heart Failure.
|
N/A | |
Recruiting |
NCT06446999 -
Yoga-Based Breathing Exercise, Colorectal Cancer Surgery
|
N/A | |
Not yet recruiting |
NCT05505188 -
Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer
|
N/A | |
Completed |
NCT04864600 -
CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles
|
N/A | |
Completed |
NCT03336177 -
Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.
|
||
Completed |
NCT06395025 -
Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group
|
N/A | |
Completed |
NCT04292665 -
Effects of Classical Massage and Benson Relaxation Exercise on Heart Failure Patients
|
N/A | |
Recruiting |
NCT05681975 -
Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
|
||
Completed |
NCT04169919 -
Modified Treatment for Epidemic Keratoconjunctivitis (EKC)
|
N/A | |
Recruiting |
NCT06436651 -
Digital Storytelling in Symptom Management Pediatric Oncology
|
N/A | |
Recruiting |
NCT04940780 -
Integrative Oncology for Patient Symptoms
|
N/A | |
Not yet recruiting |
NCT05837988 -
Construction of Symptom Network in Maintenance Hemodialysis Patients
|
||
Recruiting |
NCT05092568 -
Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service
|
||
Recruiting |
NCT03968718 -
PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice
|
N/A | |
Completed |
NCT05556707 -
Symptom Clusters and Risk Factors of COVID-19 Patients
|
||
Completed |
NCT06153680 -
Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return
|
N/A | |
Completed |
NCT04873349 -
Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients
|
N/A | |
Recruiting |
NCT06136221 -
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
|
N/A | |
Recruiting |
NCT05827406 -
A Useful Support System for Psychiatric Diagnostics and Follow-up in Adult Psychiatry and Primary Care (ASPP)
|
||
Completed |
NCT06215339 -
Diet Therapy in Hemodialysis Patients
|
N/A |